News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,237 Results
Type
Article (43250)
Company Profile (317)
Press Release (672670)
Section
Business (212762)
Career Advice (2158)
Deals (36801)
Drug Delivery (97)
Drug Development (83090)
Employer Resources (172)
FDA (16963)
Job Trends (15498)
News (359423)
Policy (34424)
Tag
Academia (2649)
Alliances (51854)
Alzheimer's disease (1236)
Approvals (16879)
Artificial intelligence (133)
Bankruptcy (362)
Best Places to Work (11854)
Biotechnology (212)
Breast cancer (113)
Cancer (979)
Cardiovascular disease (87)
Career advice (1804)
Cell therapy (225)
Clinical research (65699)
Collaboration (347)
Compensation (171)
COVID-19 (2631)
C-suite (84)
Data (917)
Diabetes (149)
Diagnostics (6340)
Earnings (87266)
Employer resources (150)
Events (113975)
Executive appointments (263)
FDA (17432)
Funding (307)
Gene therapy (163)
GLP-1 (611)
Government (4534)
Healthcare (19355)
Infectious disease (2710)
Inflammatory bowel disease (106)
Interviews (334)
IPO (16757)
Job creations (3966)
Job search strategy (1546)
Layoffs (435)
Legal (8342)
Lung cancer (160)
Manufacturing (172)
Medical device (13994)
Medtech (13999)
Mergers & acquisitions (20074)
Metabolic disorders (397)
Neuroscience (1488)
NextGen Class of 2024 (6794)
Non-profit (4563)
Northern California (1290)
Obesity (234)
Opinion (203)
Patents (99)
People (58415)
Phase I (20431)
Phase II (28881)
Phase III (21605)
Pipeline (256)
Postmarket research (2629)
Preclinical (8683)
Radiopharmaceuticals (246)
Rare diseases (192)
Real estate (6316)
Regulatory (22811)
Research institute (2396)
Resumes & cover letters (366)
Southern California (1153)
Startups (3793)
United States (12434)
Vaccines (579)
Weight loss (179)
Date
Today (251)
Last 7 days (939)
Last 30 days (3268)
Last 365 days (36615)
2024 (31860)
2023 (41202)
2022 (52474)
2021 (57193)
2020 (55787)
2019 (48578)
2018 (36641)
2017 (33857)
2016 (33443)
2015 (39499)
2014 (33079)
2013 (28253)
2012 (30499)
2011 (31057)
2010 (28926)
Location
Africa (778)
Arizona (202)
Asia (40290)
Australia (6625)
California (2929)
Canada (1207)
China (222)
Colorado (129)
Connecticut (131)
Europe (87896)
Florida (411)
Georgia (104)
Illinois (329)
Indiana (191)
Kansas (99)
Maryland (561)
Massachusetts (2379)
Michigan (160)
Minnesota (266)
New Jersey (877)
New York (872)
North Carolina (721)
Northern California (1290)
Ohio (131)
Pennsylvania (778)
South America (1193)
Southern California (1153)
Texas (416)
Utah (86)
Washington State (336)
716,237 Results for "aspen surgical products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
ClearPoint Neuro, Inc. congratulates its partner Aspen Neuroscience, Inc. on use of the ClearPoint Neuro Navigation System to transplant dopaminergic neuron precursor cells for all enrolled patients with Parkinson’s Disease in its recently launched ASPIRO Phase 1/2a clinical trial.
June 20, 2024
·
6 min read
Press Releases
Aspen Medical Products Launches First Bracing Solution Available for PJK Mitigation
August 7, 2024
·
4 min read
Press Releases
Aspen Neuroscience Announces Collaboration and License Agreement with Cell X Technologies
October 9, 2024
·
4 min read
Biotech Beach
Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)
Aspen Neuroscience, Inc. has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, to support clinical research aimed at treating Parkinson’s disease (PD).
May 15, 2024
·
4 min read
Pharm Country
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced positive topline results from the ASPEN study, a global, randomized, double-blind, placebo-controlled Phase 3 study to assess the efficacy, safety, and tolerability of brensocatib in patients with non-cystic fibrosis bronchiectasis.
May 28, 2024
·
13 min read
Biotech Beach
Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting
Aspen Neuroscience will present this week to a global audience of clinicians, regulators, researchers, technologists and industry partners at the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, May 29-June 1.
May 30, 2024
·
3 min read
Press Releases
Aspen Neuroscience Announces Expansion of Autologous Cell Therapy Manufacturing in San Diego
October 1, 2024
·
3 min read
Drug Development
Insmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis
Insmed Incorporated announced that it will host a conference call and webcast tomorrow, Tuesday, May 28, 2024, at 8:00 am ET to discuss topline results from the ASPEN study, a global, randomized, double-blind, placebo-controlled Phase 3 study to assess the efficacy, safety, and tolerability of brensocatib in patients with non-cystic fibrosis bronchiectasis.
May 27, 2024
·
2 min read
Business
Aspen Neuroscience Appoints Ana Sousa Chief Regulatory Officer
Aspen Neuroscience, Inc. announced the appointment of Ana Sousa, MSJ as the company’s Chief Regulatory Officer.
January 16, 2024
·
2 min read
Press Releases
Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at Upcoming Investor Conferences
September 30, 2024
·
1 min read
1 of 71,624
Next